Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study
Authors not listed
Casa di Cura San Raffaele Cassino · 2024
Abstract
MARKERS-NDD is a prospective, observational, longitudinal study, which aims to collect data from patients affected by neurodegenerative diseases (NDD) followed longitudinally for routine examinations performed as part of normal clinical practice. Data collected from clinical evaluations, movement analysis, brain imaging, neuropsychological and electroencephalographic assessments, blood chemistry tests will be analysed to carry out statistical investigations and predictive analyses, also using artificial intelligence systems, which allow the identification of new early markers of diagnosis and prognosis of neurodegenerative diseases.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2024). Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study. <em>Casa di Cura San Raffaele Cassino</em>. https://clinicaltrials.gov/study/NCT06596746
Vancouver
Anonymous. Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study. Casa di Cura San Raffaele Cassino. 2024.
BibTeX
@misc{anon2024Neurod,
title = {Neurodegenerative Diseases Progression Markers (MARKERS-NDD): a Real-world Data Longitudinal Prospective Study},
author = {Anonymous},
journal = {Casa di Cura San Raffaele Cassino},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University Medical Center Groningen 2022
Open access · US-GOV
Cohort Study on the Effects of Aging in Acquired Brain Injury Patients
University Hospital, Geneva 2020
Open access · US-GOV
Changes of Health-related Quality of Life 6 Months After High-risk Oncological Upper Gastrointestinal and Hepatobiliary Surgery: a Single-centre Prospective Observational Study (ChangeQol Study)
Trabzon Kanuni Education and Research Hospital 2026
Open access · US-GOV
Artificial Intelligence-Based Prediction of Sarcopenia Risk in Intensive Care Unit Patients With Intracranial Pathology
IRCCS San Camillo, Venezia, Italy 2023
Open access · US-GOV
Role of the Gut-microbiota on Ageing and Neurodegeneration: a Clinical and Brain Imaging Study
University of Novi Sad 2021
Open access · US-GOV
A Single Centre, Prospective, Two-armed Magnetic Resonance Spectroscopy Study to Compare Imaging Biomarkers of Neuroinflammation and Neurodegeneration Between HIV-positive Subjects Switched and Initially Treated With INSTI
Aging 2022
Open access · CC-BY